BCY 11864
Alternative Names: BCY-11864Latest Information Update: 11 Jun 2021
At a glance
- Originator Bicycle Therapeutics
- Class Antineoplastics; Bicyclic peptides; Immunotherapies
- Mechanism of Action CD137 antigen agonists; Cytotoxic T lymphocyte stimulants; Myeloid cell stimulants; Natural killer cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer